大行評級|麥格理:下調阿里健康目標價至3.4港元 維持“跑輸大市”評級
麥格理髮表報吿,阿里健康截至9月底止上半財年收入符合預期,盈利超出預期,主要受惠於毛利率改善。期內,電子商務廣吿業務快速增長,推動綜合平台抽傭率上升,並有利整體毛利率的表現。不過,公司銷售增長的可見性及整體醫療產品需求仍然低迷。麥格理將阿里健康今明兩個財年收入預測分別下調7%及8%,今財年調整後盈利預測上調11%,以反映上半財年較佳的盈利能力表現,不過下財年盈利預測則下調8%。因此,將公司目標價下調13%至3.4港元,維持“跑輸大市”評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.